‘Terrible’ fee environment begins to improve as IPOs return

The IPO fee wallet in EMEA ECM has shrunk dramatically in 2023
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: